Objective: To describe and assess techniques of intraoperative near-infrared fluorescence lymphography (NIRFL) using indocyanine green (ICG) for lymphatic duct identification during thoracoscopic thoracic duct (TD) ligation in dogs.
| I NT ROD UCTI ON
Thoracic duct ligation (TDL) is commonly performed as part of surgical treatment of idiopathic chylothorax. Successful resolution of chylous pleural effusion has been described with open and minimally invasive approaches to TDL. [1] [2] [3] [4] As with other minimally invasive procedures, a thoracoscopic approach to TDL offers the potential benefits of operative magnification of small structures during dissection, decreased patient morbidities, 5 and shorter hospital stays.
Regardless of operative approach, identification of all thoracic duct (TD) branches is conceptually important to minimize the risk that ducts may be missed, which might result in persistent chylous effusion. CT lymphography (CTL) may be used preoperatively to describe TD anatomy. 6 However, CTL does not directly aid in the intraoperative identification of individual lymphatics, and coloration of TDs with visible dyes such as methylene blue (MB) is commonly performed to improve TD visualization. 7 MB is often not well visualized through fat due to limitations in the depth that visible light can penetrate, 8 and peri-aortic fat deposition within the mediastinum can limit operative TD identification. An alternative, safe, and effective, high-contrast method of intraoperative TD identification could improve our ability to identify TD branches in veterinary chylothorax patients, allowing for improved TD dissection and reducing risks of technical failures. Visible light only penetrates a few hundred microns into blood and tissue; as a result, surface features of a surgical field are resolved while deeper structures remain hidden. 8 Near-infrared (NIR) fluorescence imaging systems utilize light spectra with wavelengths longer than those that can be resolved by the human eye but penetrate deeper in tissues by several millimeters. 8 Indocyanine green (ICG) is a safe and effective NIR fluorophore, useful for operative imaging of the lymphatic system as it is highly bound to plasma lipoproteins. 9, 10 The longer wavelengths of the photons emitted by appropriately stimulated ICG in the NIR spectrum allow for the ability to see NIR-highlighted structures deeper in mediastinal fat than possible as viewed by eye under white light. Information on the use of ICG for near-infrared fluorescence lymphography (NIRFL) of the TD is currently limited. [11] [12] [13] [14] [15] We hypothesized that with direct NIRFL (fluorophore injection into a lymph node [LN] draining to the TD), the TDs in client-owned dogs presenting for chylothorax would be consistently identified, and that the number and location of TD branches identified by NIRFL would match those identified by preoperative CT lymphangiography. The overall aims of this study were to: (1) describe our early experiences using direct intranodal ICG NIRFL for TD identification and ligation in a cohort of dogs with chylothorax, (2) to identify an effective dose range of ICG for illumination of the TD, and (3) to describe the caudodorsal mediastinal lymphatic anatomy identified in the patients studied.
| M ATE RI ALS AN D ME THO DS

| Inclusion criteria and patient data
Medical records of dogs with a presumptive diagnosis of idiopathic chylothorax that underwent thoracoscopic TDL utilizing NIRFL at the University of California-Davis Veterinary Medical Teaching Hospital were retrospectively identified and reviewed. Dogs were included if they were screened for underlying causes of chylothorax preoperatively, resulting in a presumed diagnosis of idiopathic etiology, and if they received intraoperative NIRFL to direct thoracoscopic TDL. Individual anesthetic and postoperative management protocols were determined by the attending clinicians. Data retrieved from the medical records included dog signalment, weight, body condition score (BCS) on a scale of 1-9, CT lymphography and surgical data, fluorophore dose and injection site, concurrent use of MB as an optical lymphatic dye, timing of TD identification, and clinical status as assessed by the dogs' owners at 2 weeks postoperatively. Follow-up data on clinical status in order to identify any later (postdischarge from hospital) adverse reactions to NIRFL was obtained by review of medical records or telephone interview with clients.
| Direct CT lymphography
CTL was performed according to previously published protocols 6 using nonionic iodinated contrast material (Isovue 370; Bracco Diagnostics, Princeton, New Jersey) injected directly into the substance of a LN under ultrasound guidance. Mesenteric lymph node (MLN) injection was attempted first in in all dogs; if this was deemed impossible or attempts failed, injection of the medial iliac (MILN) or popliteal (PLN) lymph nodes were attempted. Data retrieved included the location that resulted in a successful direct CTL study, and the numbers and positions of TDs identified. If postoperative CTL was performed, the TD was considered ligated if there was abrupt termination of contrast within the TD at the surgical site with no evidence of contrast medium dispersion into the mediastinum.
| Surgical technique
Dogs were positioned in lateral 4 or sternal 16 recumbency at the preference of the operating surgeon. A 3-port technique was used for thoracoscopic TDL as previously described. 4 All dogs received a pericardectomy after thoracoscopic TDL, and the approach and technique was determined according to the preference of the operating surgeon; patients were repositioned as needed. For thoracoscopic TDL, side of approach was determined by CTL identification of TD position and operating ports were placed in a variety of configurations at the discretion of the operating surgeon; in general, ports were placed in a triangulating pattern in mid to dorsal thorax at the 7th to 10th intercostal spaces. In all cases, a 3-port technique was used, with a combination of 6-mm nondisposable trocarless threaded cannulae (Endotip, Karl Storz Veterinary Endoscopy, Goleta, California), 10-mm trocarless threaded cannulae (Karl Storz Veterinary Endoscopy), and 11.5-mm disposable threaded cannulae (Thoracoport, Covidien, Mansfield, Massachusetts 
| Postoperative management
A thoracostomy tube was placed in all dogs for monitoring of the pleural space during recovery. After recovery from general anesthesia, dogs were administered parenteral opiate analgesics as determined by the attending clinicians (fentanyl constant rate infusion [0.02-0.3 mcg/kg/min], intermittent hydromorphone or oxymorphone 0.05 mg/kg every 4-6 hours either intravenously or subcutaneously) to manage postoperative discomfort. Thoracostomy tubes were removed at the discretion of the attending clinician, and dogs were discharged with oral tramadol (2-4 mg/kg every 6-12 hours) and/or oral carprofen (2 mg/kg every 12 hours) to be administered at home if deemed necessary by the owner. (1), and Golden Retriever mix (1). There were 7 spayed females, 7 castrated males, and 1 intact male. The median age of dogs at presentation was 4.5 years (range, 1.5-12 years). The median body weight of dogs was 28.8 kg (range, 4.6-60.3 kg) and the median BCS (on a scale from 1 to 9) was 5 (range, 3-8).
| RES U LTS
| Patient data
| CT lymphography
Computed tomography (CT) scans were performed under the same anesthetic as the TD ligation procedure in 12/15 dogs, and under separate anesthetic events in 3/15 dogs. Preoperative ultrasound-guided intranodal injection of iopamidol was successful in 13/15 dogs ( Figure 1 ). Injection into multiple LN locations was attempted but opacification of the TD was never achieved in the 2 dogs in which preoperative CTL failed; these were the largest (60.3 kg) and the smallest (4.6 kg) dogs in the study. Injection of the MLNs was attempted in 10/15 dogs and was successful in 7. In 5 dogs, MLNs were deemed too small or otherwise inaccessible, and injection of alternative LNs was elected from the onset. Other CTL injection sites that successfully illuminated the TDs included the MILNs (n 5 3) and the PLNs (n 5 3). TD anatomy was complex with a total of 2 TD branches identified by CTL in 3/13 dogs, and 3 or more branches identified by CTL in 10/13 dogs; further description is provided in Table 1 . The location, size, and overall morphology of the cisterna chyli was highly variable across individuals, but was identified in the retroperitoneum ventral to vertebral bodies of T12-L3. Three dogs did not exhibit a clear regional lymphatic dilation identifiable as the cisterna chyli. TDs were identified in aberrant locations (not in the mediastinum just dorsal to the aorta) that would have likely not been easily localized intraoperatively without preoperative CTL identification in 5/13 dogs. In one case, one TD passed through the diaphragm dorsal to the aorta with other separate TDs, but immediately dropped ventrally along the right side of the aorta, running along the diaphragmatic surface and then cranially through the mediastinum ventrolateral to the aorta. In another case, one branching TD was identified ventrolateral to the aorta on the left side at the level of T10-T12 and would have been missed from a right-sided approach if ligation had not been performed caudal to this region. In another case with 2 identified TDs, one duct exhibited a "normal" anatomic pattern in the caudodorsal mediastinum, but the other exited the cisterna chyli separately, dived ventrally within the abdomen and passed through the diaphragm at the esophageal hiatus, and continued cranially in the chest along the left side of the esophagus. In another case, a TD branch dived left and ventrally at the level of T11, ran lateral to the esophagus in the left hemithorax and completely encircled the aorta at the level of T8. And in the final case, one TD branch was identified coursing very laterally in the ventrolateral aspect of the ventral spinal musculature in the caudal thorax. Contrast leakage from the TD was identified by CTL in 3/13 dogs and was located within the mediastinum cranial to the heart in all 3 cases.
| Surgical approach
The side of thoracoscopic surgical approach was chosen based on CTL in all dogs in which CTL was obtained; in 14/ 15 dogs, a right-sided approach and in 1/15 dogs a left-sided approach was elected. The 2 dogs in which CTL failed and no preoperative data on TD numbers and position were In addition to the thoracoscopic TDL procedure, in 13/15 dogs a thoracoscopic sub-phrenic pericardectomy was performed. In 1/15 dogs, an intercostal pericardectomy was elected due to staffing issues, and in 1/15 dogs an intercostal pericardectomy and right middle lung lobectomy was performed due to a lung lobe torsion with chronic mature adhesions to the body wall and other lung lobes that could not be successfully managed thoracoscopically. The median surgical time for all cases was 3.6 hours (range, 2.75-4.5 hours), which included pericardectomy, and the median duration of anesthesia was 7.5 hours (range, 5-11 hours), which also included time for the CTL study in the dogs in which CTL was performed under the same anesthetic event as the surgical procedure.
| Intraoperative lymphography
Ten dogs received a combination of MB and ICG for intraoperative lymphography. The first 9 dogs in which NIRFL imaging was performed received injection of a mixture of MB and ICG for initial TD identification. Six subsequent dogs received NIRFL with ICG alone for initial TD identification. One of these 6 dogs then received reinjection lymphography with a combination of ICG and MB after clip placement to confirm TD attenuation (Figure 2 ). Primary 
The number of thoracic ducts identified by CT lymphography ventral to each vertebral body in the caudal thorax in the 13 dogs in which CTL was achieved, expressed as median (range).
operative injection sites were the MLNs (n 5 3), indirect injection into the perinodal fat at the mesenteric root (n 5 1), PLNs (n 5 7), or more than one site (n 5 4). Dogs that received injections in multiple sites did so because an initial attempt at PLN injection failed to result in opacification of the TD by either NIRFL or visible MB 10 minutes after injection. Dogs who received indirect injections into the mesenteric root did so because MLNs could not be clearly visualized or palpated within the mesenteric fat and direct intranodal injection attempts were unsuccessful. In one case in which PLN injection was unsuccessful, the attempted PLN injection was performed percutaneously based on palpation, and it is likely that true intranodal injection was not achieved and ICG was instead delivered subcutaneously into the perinodal fat. Subsequently, the NIRFL protocol was adapted to include a small surgical approach to directly visualize the PLN in the remaining cases. When the injectate was administered slowly and in intermittent pulses, LN volume was observed to swell, and then shrink again as injectate was carried forward with lymphatic flow. In 2 dogs in which NIRFL via PLN injection was unsuccessful, the PLN was very small and unable to accept any reasonable volume of contrast, with injectate immediately leaking into the perinodal tissues. In a final dog in which injection of a very small PLN was attempted by open approach, severe contrast leakage from the PLN was again observed. After 15 minutes, no opacification of the TD was observed, and a paracostal approach to the MLNs was initiated. At 25 minutes post-PLN injection, prior to injecting the MLN with additional ICG, the caudal mediastinum was visually inspected and strong fluorescence was noted highlighting the TDs, so the planned ICG injection into the MLN was aborted. The median total dose of administered ICG to achieve NIRFL imaging in all 15 dogs was 1 mg (range, 0.13-5 mg) and the median dose of ICG/kg of body weight to achieve NIRFL imaging was 0.05 mg/kg (range, 0.01-0.32 mg/kg). The median dose of ICG/kg of body weight to achieve NIRFL in the 7 dogs in which this was achieved via the PLN was 0.05 mg/kg (range, 0.02-0.13 mg/kg). The median volume of injectate introduced into the PLN in these 7 dogs was 0.19 mL/kg of body weight (range, 0.06-0.40 mL/kg). The median dose of ICG/kg of body weight to achieve NIRFL in the 5 dogs in which this was achieved via a MLN was 0.11 mg/kg (range, 0.02-0.13 mg/kg). The median volume of injectate introduced into a MLN in these 5 dogs was 0.07 mL/kg of body weight (range, 0.06-0.40 mL/ kg). Additional dose and volume data of ICG and MB administered for intraoperative lymphography are provided in Table 2 .
| Quality and timing of NIRFL
The quality of NIRFL achieved was assessed by the grading scheme described above. NIRFL was attempted by MLN injection alone in 4 dogs. NIRFL was attempted first by PLN injection in 11/15 dogs; in 7/11 cases, TD fluorescence was achieved: 1/7 cases exhibited grade 1 fluorescence (present), 6/7 cases exhibited grade 2 fluorescence (ideal), and no cases exhibited grade 3 fluorescence (excessive). Four of the 11 cases were assigned a grade of 0 (absent) at 10 minutes post-PLN injection, and the MLNs (2/4) or mesenteric root (2/4) were subsequently injected. The times to observed fluorescence following PLN injection of ICG were recorded as follows: <2 minutes (n 5 2), 2-5 minutes (n 5 4), and between 15 and 25 minutes (n 5 1). Five total cases received direct ICG injection into a MLN: 2/5 cases exhibited grade 2 fluorescence and 3/5 cases exhibited grade 3 fluorescence. The times to observed fluorescence following MLN injection of ICG were <1 minute in all cases (and often occurred within just a few seconds). A total of 3 cases received indirect NIRFL by injection of ICG into the fat at the mesenteric root but not directly into a MLN: 2/3 of these cases demonstrated grade 1 fluorescence of the TD and 1/3 cases exhibited grade 2 fluorescence. The times to observed fluorescence following mesenteric root injection of ICG were <3 minutes, <5 minutes, and <13 minutes; the TD was not observed continuously after mesenteric root injection as the surgeon was often occupied with other operative tasks such as additional port placement, and the time recorded is when intermittent observation identified fluorescence. Dissection of the dorsal mediastinal pleura was initiated after a fluorescent glow in the area was noted in the initial 3 dogs. However, while diffuse fluorescence could be seen through the peri-aortic fat of the dorsal mediastinum, individual TDs could not be discretely identified through the pleura and mediastinal fat until the pleura was incised and retracted. Because of this, in subsequent dogs, the parietal pleura overlying the region of the dorsal aorta was incised prior to initiation of NIRFL in the remaining 12 dogs. In 4/15 dogs, a phenomenon of recirculation fluorescence was observed. This manifested as diffuse background fluorescence in the intrathoracic tissues that appeared to be associated with vascular delivery of ICG throughout the chest. This was notable in that it caused loss of some of the inherent contrast of NIRFL and mild to moderate visual impairment in differentiating the TDs from mediastinal tissues under NIR light. Of the 4 dogs in which this was observed, 3 dogs were those in which the mediastinum was incised and dissection begun only after LN injection was completed and fluorescence was already noted in the region of the TDs, and the fourth dog experienced an initially incomplete attenuation of the TD with hemoclips, resulting in prolonged duration of lymph flow after ICG injection. When this was noticed due to continued fluorescent flow through the TD and failure of the duct caudal to the clips to distend with fluid, additional clips were placed, resulting in successful attenuation. Subjectively, the authors found that certain technical aspects contributed to an optimal NIRF lymphangiographic study and summary recommendations are provided in Table 3 .
| Comparison of NIRFL with other methods of lymphography
The TDs identified by NIRFL imaging were the same with TDs identified by preoperative CTL in 12/13 cases in which CTL was achieved. In 1/13 cases, NIRFL additionally identified a crisscrossing network of very small, wispy lymphatics in the region of larger TDs; these were not able to be resolved on CTL. Of the 10 cases in which MB was combined with ICG for intraoperative lymphography, either preligation or postligation, data on the quality of visible MB lymphography compared to NIRFL were available for 9 dogs. In 5/9 cases, no ducts or fewer TDs were recorded as identifiable by visible MB than by NIRFL or CTL. Subjectively, the strength of TD coloration by visible MB faded more quickly than the NIRF coloration in all cases in which both MB and ICG were used, although specific quantification and timings of this phenomenon were not recorded.
| Assessment of TD ligation
Adequacy of TD ligation was confirmed by postoperative CTL in 2/15 dogs that showed termination of intralymphatic contrast at the surgically placed hemoclips and no opacification of novel lymphatic ducts, and in 10/15 dogs by repeat postligation NIRFL that showed distension of the cisterna chyli with no additional fluorescence cranial to the placed hemoclips, nor identification of additional lymphatics. Postligation CTL or NIRFL was planned, but was not achieved in 5 dogs due to timing or technical issues.
| Notable operative events
Other notable procedural events relative to NIRFL and thoracoscopic TD ligation in this cohort included a small TD tear during dissection leading to leakage of chyle that was only identified during NIR illumination (not under standard white light) in 2/15 cases. Cessation of fluid leakage was achieved by more caudal clip placement and visually confirmed during NIR illumination in both cases. In one case, the laparoscopic clip applier jammed intraoperatively. A SurgiClip clip applier (Medtronic Inc) was introduced through a 12-mm Thoracoport under thoracoscopic visualization, and clip application allowed for successful TD attenuation.
| Follow-up data
All dogs were recovered with thoracostomy drains and monitored in the intensive care unit in the initial 24 hours after surgery. Median time to discharge was 2 days after surgery (range, 2-4 days). All dogs were discharged from the hospital, and doing well per telephone communications with clients at 2 weeks postoperatively. No dogs experienced adverse events before or after hospital discharge.
| D IS C US S I ON
We report a technique of intraoperative direct lymphangiography using NIR fluorescence imaging, which provides an effective method to identify TD branches for thoracoscopic TDL in dogs. NIR fluorescence was not associated with any identified patient complications, and demonstrated excellent, high-contrast definition of the TDs and their branches in this cohort of dogs, and fluorescence was detectable even through several millimeters of fat. All TDs identified by CTL were successfully identified with NIRFL.
Improvements in diagnostic imaging techniques in recent decades have highlighted the relative anatomic variability in the lymphatic pathways of dogs. Operative methods of lymphangiography improve the identification of anticipated TDs and enhance the surgeon's ability to ensure complete ligation of all TDs. Prior reports of operative lymphangiography have most commonly used MB for direct coloration of the TDs. Direct operative lymphography may be achieved via direct cannulation of a lymphatic vessel or injection into a LN. 7, 17 Lymphatic cannulation can be technically challenging, and operative lymphography using MB is commonly achieved via injection into a MLN. Prior work using operative MB lymphography demonstrated that injection of the PLN with MB was successful in staining the TD in 60% of dogs whereas injection of the MLN was successful in coloring the TD in 100% of dogs, 7 consistent with MB lymphography results in our study. Successful NIRFL results were also similar as TD fluorescence was identified in 10 minutes by PLN injection in 7/11 cases (64%; 3 cases subsequently received mesenteric injection, case 12 demonstrated delayed NIRFL likely as a result of indirect lymphography from observed severe injection site leakage), MLN injection in 5/5 cases (100%) and indirect mesenteric root injection in 3/3 cases (100%). However, the impact of case selection and the learning curve in applying a new technique may have negatively impacted the success of popliteal NIRFL as 2 were among the first of the cohort. The 2 dogs later in the cohort in which PLN injection was unsuccessful were small in size, with LNs that did not accept even small bolus injections, and exhibited a great deal of injectate leakage from the LN capsule puncture sites, so the volume of intralymphatic ICG successfully administered these animals is questionable.
Continued assessment of success rates with PLN NIRFL in a larger cohort of animals with a more standardized protocol is recommended.
There are a number of factors that may contribute to the overall success and timing of coloration of the TD sufficient to allow for successful identification at the imaging site (including volume and concentration of injectate, the volume of distribution of the lymphatic system between injection site and imaging site, and rate of lymph flow) that are often not well defined or often easily calculable in a clinical patient. In pigs, successful indirect lymphography with ICG was achieved with an injected dose of 0.036 mg/kg of ICG, similar in scale to the median dose of 0.05 mg/kg of ICG used to successfully achieve NIRFL via PLN injection in our study. 11 It was the impression of the authors that administration of sufficient volume of vital dye intranodally was difficult if the PLN was small in size; it was difficult to control injection volume in slow boluses and leakage of a large proportion of vital dye volume from the PLN occurred even when administered through a 27-gauge needle; as a result it is unlikely that these patients in which PLN injection failed truly received the intended ICG dose. Direct PLN injection was most successful when the pole of the LN was approached surgically, directly visualized and stabilized for injection, and when the injectate was given slowly and intermittently, allowing efferent lymphatic flow to carry the injectate volume out of the PLN between pulses in order to minimize intranodal pressure buildup. While direct lymphography was attempted in all cases, in 4 cases direct intranodal injection was not successful and indirect lymphography (injection into perinodal fat) was inadvertently performed. Indirect lymphography can be successful as lymphatic capillaries have microscopic anatomy that allows passage of larger molecules, such as the vital dyes, into the lymphatic lumen. 18 However, it is likely more challenging to attain sufficient vital dye concentration within the TD lumen with indirect lymphography than with direct intranodal injection. While case numbers are small and assessment of indirect lymphography was not the purpose of this study, this is likely the explanation for why 0/1 cases of indirect MB lymphography was successful in highlighting the TD, while 4/4 cases of indirect NIRFL were successful in highlighting the TD. NIRFL may offer a conceptual advantage over visible vital dyes in this regard. Because of the relatively high signal-to-background fluorescence imaging provides, the concentration of ICG at the imaging site necessary to achieve fluorescence is often much lower than that needed to achieve visual coloration of the duct. In pigs, oral administration of heavy cream or injection of MB directly into a groin LN provided relatively poor TD contrast compared to indirect NIRFL using ICG.
11
Other notable procedural events relative to NIRFL and thoracoscopic TD ligation in this cohort included TD trauma during dissection resulting in very small volumes of chyle leakage that was only was only noted under NIR light. Because of the small sizes of the lymphatic tear and lack of identification when observed under white light, it is the opinion of the authors that this leakage would likely have been missed under standard optical dissection alone. Whether or not this leakage would have resulted in continued pleural fluid accumulation postoperatively in these animals is unknown, but it is logical that undiagnosed TD tears occurring during the course of dissection could result in persistent chylothorax.
The doses of ICG used to achieve NIRFL of the TD by mesenteric injection 12 and indirect subcutaneous injection 13, 14 reported in the limited human case reports were much higher than that required for successful TD NIRFL in our study, although different imaging systems were used by these authors than the one reported here. This is important to note, as device performance relies on a variety of factors. 19 This study provides important baseline information for setting the dosing and detection levels of ICG for NIRFL in dogs, but inevitably dosing and detection levels may be specific to the particular imaging device used, and this may become important as more NIR devices enter the veterinary market.
An important operative benefit of NIRFL over MB lymphography is that the diluted concentrations (relative to the injected concentration) of ICG at the level of the TD were sufficient to provide strong fluorescence, but leakage of ICG-carrying chyle during dissection in pigs did not result in visible staining of the surgical site under standard white light that might compromise dissection, 11 consistent with limited observations of chyle leakage in 2/15 cases in our cohort of dogs, which was only visible when viewed in the NIR spectrum. This is a positive attribute compared to MB, as contact with MB can result in visible staining of tissues that might be inhibitory to identification of small regional structures and make dissection more challenging. The observed phenomenon of recirculation fluorescence manifested as diffuse background fluorescence in the intrathoracic tissues, and as a result reduced contrast with mild to moderate visual impairment in differentiating the TDs from mediastinal tissues under NIR light. This could potentially be a limiting factor to successful NIRFL for TD ligation. In all of the cases in which this was observed, flow of chyle containing ICG continued through the TD to empty into the venous system for a longer duration of time than those cases in which recirculation fluorescence was not observed, due to longer dissection times or incomplete attenuation of the TD.
| CON CLU S IO N
NIRFL is a viable technique for TD identification during thoracoscopy. High contrast NIRF illumination of the TD can be achieved with successful intra-parenchymal injection of ICG into the PLN, which spares the patient the morbidity associated with a paracostal approach to the MLNs, although a small surgical approach to the PLN is recommended to optimize NIRFL. Indirect NIRFL may also be a viable technique in dogs, although the need for dosing or timing modifications are not well understood and should be studied further.
